These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 966157)

  • 21. Effects of 15-oxa-32-vinyl-lanost-8-ene-3 beta,32 diol on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein receptor in rat liver.
    Ness GC; Lopez D; Chambers CM; Zhao Z; Beach DL; Ko SS; Trzaskos JM
    Arch Biochem Biophys; 1998 Sep; 357(2):259-64. PubMed ID: 9735166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes.
    Yamamoto A; Hoshi K; Ichihara K
    Eur J Pharmacol; 1998 Nov; 361(1):143-9. PubMed ID: 9851551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solubilization and purification of beta-hydroxy-beta-methylglutaryl coenzyme A reductase from rat liver.
    Kawachi T; Rudney H
    Biochemistry; 1970 Apr; 9(8):1700-5. PubMed ID: 4985697
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypocholesterolemic indole-2-carboxylic acids.
    Kariya T; Grisar JM; Wiech NL; Blohm TR
    J Med Chem; 1972 Jun; 15(6):659-62. PubMed ID: 5030934
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of pravastatin on hepatic 3-hydroxy-3-methylglutaryl CoA reductase obtained from poloxamer 407-induced hyperlipidemic rats.
    Johnston TP; Palmer WK
    Pharmacotherapy; 1997; 17(2):342-7. PubMed ID: 9085326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
    Keller RK; Zhao Z; Chambers C; Ness GC
    Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New hypocholesterolemic abietamide derivatives. I. Structure-activity relationship.
    Fujita Y; Sempuku K; Kitaguchi K; Mori T; Murai H; Yoshikuni Y; Enomoto H; Löser R
    Chem Pharm Bull (Tokyo); 1980 Feb; 28(2):453-8. PubMed ID: 7389019
    [No Abstract]   [Full Text] [Related]  

  • 28. A potent, tissue-selective, synthetic inhibitor of HMG-CoA reductase.
    Balasubramanian N; Brown PJ; Catt JD; Han WT; Parker RA; Sit SY; Wright JJ
    J Med Chem; 1989 Sep; 32(9):2038-41. PubMed ID: 2769677
    [No Abstract]   [Full Text] [Related]  

  • 29. Specificity of the effect of dietary cholesterol on rat liver microsomal 3-hydroxy-3-methylglutaryl-coenzyme a reductase activity.
    Gregory KW; Booth R
    Biochem J; 1975 May; 148(2):337-6. PubMed ID: 168888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase. In vitro inhibition by a protein present in bile.
    McNamara DJ; Rodwell VW
    Arch Biochem Biophys; 1975 Jun; 168(2):378-85. PubMed ID: 237479
    [No Abstract]   [Full Text] [Related]  

  • 31. 2-Amino-2-oxazolines, III: Synthesis, structure, and preliminary pharmacological evaluation of cycloaddition compounds with unsaturated carboxylic esters.
    Forfar I; Jarry C; Leger JM; Carpy A
    Arch Pharm (Weinheim); 1990 Nov; 323(11):905-9. PubMed ID: 2080898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. 1976.
    Endo A; Kuroda M; Tanzawa K
    Atheroscler Suppl; 2004 Oct; 5(3):39-42. PubMed ID: 15531273
    [No Abstract]   [Full Text] [Related]  

  • 33. Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with cAMP and wth protein fractions of rat liver cytosol.
    Beg ZH; Allmann DW; Gibson DM
    Biochem Biophys Res Commun; 1973 Oct; 54(4):1362-9. PubMed ID: 4356818
    [No Abstract]   [Full Text] [Related]  

  • 34. beta-hydroxy-beta-methylglutaryl coenzyme A hydrolase of rat liver.
    Sipat AB; Sabine JR
    Biochim Biophys Acta; 1981 Oct; 666(1):181-90. PubMed ID: 6170340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of dietary cholesterol on rat liver microsomal 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity.
    Baqir YA; Booth R
    Biochem Soc Trans; 1977; 5(1):294. PubMed ID: 892188
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis and biological activity of new 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase inhibitors: 2-oxetanones with a side chain mimicking the folded structure of 1233A.
    Hashizume H; Ito H; Yamada K; Nagashima H; Kanao M; Tomoda H; Sunazuka T; Kumagai H; Omura S
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):512-20. PubMed ID: 7911741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The activity of beta-hydroxy-beta-methylglutaryl-CoA reductase in the soluble fraction of rat liver].
    Poliakova ED; Dizhe EB; Klimova TA; Petrova LA; Klimov AN
    Biokhimiia; 1976 Nov; 41(11):2037-42. PubMed ID: 14723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dog liver 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Ho PP; Esterman MA; Towner RD; Turner RK
    Enzyme; 1977; 22(4):242-8. PubMed ID: 880941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypocholesterolemic agents. II. Inhibition of -hydroxy- -methylglutaryl coenzyme A reductase by arylalkyl hydrogen succinates and glutarates.
    Boots MR; Boots SG; Noble CM; Guyer KE
    J Pharm Sci; 1973 Jun; 62(6):952-7. PubMed ID: 4576426
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis of arylnaphthalenyl derivatives: inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductase.
    Mewshaw RE; Hild EK; Commons TJ; Strike DP
    Drug Des Deliv; 1988 Nov; 3(3):235-43. PubMed ID: 3255330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.